UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
CHA Biotech wins patent for skin aging-related stem cell culture medium
CHA Biotech said Monday that it has acquired a patent for a stem cell cultu...
by Lee Han-soo
|
2018-02-12 15:38
라인
4 drugmakers, biotech firms to list on KOSDAQ in February
The listing of pharmaceutical and biotech companies on the KOSDAQ market wi...
by So Jae-hyeon
|
2018-02-12 14:19
라인
Medytox submits new drug application for Botox in China
Medytox said Friday that it has submitted a new drug application (NDA) for ...
by Lee Han-soo
|
2018-02-09 15:28
라인
Swiss President visits Samsung BioLogics
Swiss President Alain Berset visited Samsung BioLogics headquarters in Song...
by Lee Han-soo
|
2018-02-09 15:08
라인
Tego applies for P3 clinical trials for tendon rejuvenation therapy
Tego Science said Wednesday that it has applied to initiate phase 3 clinica...
by Lee Han-soo
|
2018-02-07 11:38
라인
Medipost gets FDA nod for Alzheimer treatment
Medipost said Monday that it has received U.S. Food and Drug Administration...
by Lee Han-soo
|
2018-02-05 14:38
라인
Biosimilar body backs Pfizer against J&J blocking Celltrion’s biosimilar
The Association for Accessible Medicines (AAM)’s Biosimilars Council suppor...
by Lee Han-soo
|
2018-02-02 17:13
라인
Hugel completes merger with subsidiaries
Hugel said Friday that the company has completed its merger with two subsid...
by Lee Han-soo
|
2018-02-02 15:02
라인
Analysts raise target stock price for Samsung BioLogics
Analysts at securities companies have raised target stock price for Samsung...
by Lee Han-soo
|
2018-02-02 12:25
라인
Bio-fever to continue as companies apply for KOSDAQ listing
The bio-fever in Korea's stock market will continue this year as more t...
by Lee Han-soo
|
2018-01-31 15:35
라인
Overheated DHP Korea stocks face short-term trade limit
DHP Korea, a manufacturer of eye drops and other ophthalmic agents, faced a...
by Nam Doo-hyun
|
2018-01-31 15:34
라인
Korean biosimilars expand global presence
Korean biosimilar drugs have begun to expand their presence in the global m...
by So Jae-hyeon
|
2018-01-31 11:51
라인
Medipost turns profitable after posting record sales
Medipost said Tuesday that it recorded 42.2 billion won ($39.3 million) in ...
by Lee Han-soo
|
2018-01-30 17:44
라인
Bridge Bio submits IND application for ulcerative colitis treatment
Bridge Biotherapeutics said Monday that it has submitted its first investig...
by Lee Han-soo
|
2018-01-29 13:42
라인
GC Lab Cell expects sales growth to continue
GC Lab Cell, a cell therapy developer, said Friday that it recorded 45.8 bi...
by Marian Chu
|
2018-01-26 18:23
라인
Competition heats up over Rituximab market share
The competition among pharmaceutical companies to carve out a larger share ...
by Lee Han-soo
|
2018-01-26 17:58
라인
Samsung Bioepis records robust earnings in the EU
The sales of Samsung Bioepis’ Benepali (Original: Enbrel) and Flixabi (Orig...
by Lee Han-soo
|
2018-01-26 14:03
라인
Patent applications for doping detection rise
Technologies used to detect doping are once again in the limelight as the 2...
by Marian Chu
|
2018-01-25 19:32
라인
GemVax & KAEL finds new implication for anticancer drug
GemVax & KAEL said Thursday that GV1001, also known as Riavax, has the pote...
by Lee Han-soo
|
2018-01-25 18:13
라인
Tech developed to detect diseases with single drop of fluid
Korean researchers have developed a new biosensor technology that can quick...
by Marian Chu
|
2018-01-25 12:00
-
이전
21
22
23
24
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top